We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alzheimer's Tangles May Be Protective

By Biotechdaily staff writers
Posted on 05 May 2005
The nerve tangles seen in the brains of people with Alzheimer's disease (AD) may not be the cause of the disease but rather a protective response to the disease, according to new findings by researchers at Case Western Reserve University School of Medicine (Cleveland, OH, USA).

The major component of neurofibrillary tangels (NFTs) is a protein called tau, which has undergone a biochemical reaction called phosphorylation. More...
It has been assumed that NFTs are the cause of the progression to AD and nerve cell death. However, these tangles also occur in all brains with age, although there are a lot more in the brains of people with AD. Tau phosphorylation or fibril formation is unlikely to be the cause of neuronal death since NFT-bearing neurons appear to survive for decades. One study found that neurons containing NFTs can survive as long as 20 years.

There is growing evidence that oxidative stress is a significant factor in the development of AD. Free radicals and reactive oxygen species oxidize tissues. This damages membranes and DNA, disrupting normal cell function and leading to nerve cell death.

"Since oxidative stress is decreased in neurons bearing NFTs, we suspect that the accumulation of tau proteins might actually be a protective, antioxidant response that serves as a mechanism for cells to defend themselves,” explained senior author Mark A. Smith, Ph.D., professor of pathology at Case.

The fact that the embryonic neurons that survive after treatment with oxidants have increased tau phosphorylation relative to those that die further supports a protective role for tau phosphorylation. Also, NFT-like tau phosphorylation occurs during hibernation, which is a neuroprotective pnenomenon. The researchers also believe that amyloid-beta may be neuroprotective and may be an antioxidant. A paper explaining their position appeared in the April 2005 issue of Trends in Molecular Medicine.




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.